Iskra guidelines on antimicrobial treatment and prophylaxis of urinary tract infections - Croatian national guidelines;Iskra smjernice antimikrobnog liječenja iprofilakseinfekcija mokraćnog sustava - Hrvatske nacionalne smjernice

Lijecnicki Vjesnik

Volumn 131, Issue 5-6, 2009, Pages 105-118

  Škerk, Višnja ^a   Andrašević, Arjana Tambić ^a   Andrašević, Saša ^a   Sušić, Edita ^a   Džepina, Mlinarić ^a   Madarić, Vesna ^a   Milutinović, Slobodan ^a   Ivan, Krhen ^a   Perić, Ljiljana ^a   Jugoslav, Bagatin ^a   Ćorić, Mario ^a   Daniel, Ferlin ^a   Irina, Cazin ^a   Gordana, Tomac ^a  

^a Klinika za Infektivne Bolesfi   (Croatia)

Author keywords

Antiinfective agents, urinary therapeutic use; Bacterial infections drug therapy; Croatia; Practice guidelines as topic; Urinary tract infections classification, diagnosis, drug therapy

Indexed keywords

ADULT; ARTICLE; CHILD; FEMALE; HUMAN; MALE; PRACTICE GUIDELINE; URINARY TRACT INFECTION;

ADULT; CHILD; FEMALE; HUMANS; MALE; URINARY TRACT INFECTIONS;

EID: 68149160958     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (118)

1. The AGREE Collaboration. Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument. URL: http://www.agreecollaboration.org/
2. Škerk V, Krhen I, Kalenić Sisur. Smjernice antimikrobnog liječenja i profilakse infekcija mokraćnog sustava. Liječ Vjesn 2004;126:169-81.
3. Škerk V, Tambić Andrašević A, Andrašević S i sur. Prijedlog smjemica antimikrobnog liječenja i profilakse infekcija mokraćnog sustava - 2006. godina. Infektol Glasn 2006;26:47-52.
4. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer J, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999;29: 745-58.
5. Naber KG, Bishop MC, Bjerklund-Johansen TE i sur. Guidelines on the management of urinary and male genital tract infections. Netherlands: European Association of Urology; 2006.
6. Scottish Intercollegiate Guidelines Network. Management of suspected bacterial urinary tract infections in adults: a national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network; 2006.
7. Geerlings SE, van den Broek PJ, van Haarst P i sur. Optimalization of the antibiotic policy in the Netherlands: SWAB guidelines for antimicrobial therapy for complicated urinary tract infections (UTIs). Netherlands: The Working Party on Antibiotic Policy (SWAB); 2006.
8. Tambić T, Tambić-Andrašević A. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2000. g. Zagreb: Akademija medicinskih znanosti Hrvatske; 2001.
9. Tambić T, Tambić-Andrašević A. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2001. g. Zagreb: Akademija medicinskih znanosti Hrvatske; 2002.
10. Tambid T, Tambid-Andrašević A. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2002. g. Zagreb: Akademija medicinskih znanosti Hrvatske, 2003.
11. Tambid T, Tambić-Andrašević A. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2003. g. Zagreb: Akademija medicinskih znanosti Hrvatske; 2004.
12. Tambić T, Tambić-Andrašević A. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2004. g. Zagreb: Akademija medicinskih znanosti Hrvatske; 2005.
13. Tambić T, Tambić-Andrašević A. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2005. g. Zagreb: Akademija medicinskih znanosti Hrvatske; 2006.
14. US Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research (AHCPR). URL: http://www.ahcpr.gov/ clinic/epcindex.htm#methodology
15. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992;15 (suppl 1):S216-27.
16. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE with modifications by a European Working Party (Norrby SR). General guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infection. Taufkirchen, Germany: The European Society of Clinical Microbiology and Infectious Diseases; 1993, str. 294-310.
17. Prins JM, Büller HR, Kuijper EJ, Tange RA, Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993-341:335-9.
18. Prins JM, Weverling GJ, De Blok K, Van Ketel R, Speelman P. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy. Antimicrob Agents Chemother 1996;40:2494-9.
19. Vrhovac B, ur. Farmakoterapijski priručnik. Zagreb: Medicinska naklada; 2007.
20. Bencarič L. Registar lijekova u Hrvatskoj. Zagreb: Udruga poslodavaca u zdravstvu; 2007.
21. Auckenthaler R. Modern concept of antibiotic therapy of urinary tract infections. Adv Exp Med Biol 2000;485:279-87.
22. Hamilton-Miller J. Cefixime for switch therapy. Chemotherapy 1998-44 (Suppl 1):24-7.
23. Orenstein R, Wong ES. Urinary tract infections in adults. Am Fam Physician 1999;59:1225-34.
24. Cunha BA. Intravenous to oral antibiotic switch therapy. Drugs Today 2001;37:311-9.
25. Sevinc F, Prins JM, Koopmans RP, Langendijk PN, Dankert J, Speelman P. Early change from intravenous to oral antibiotics: switch therapy. Ned Tijdschr Geneeskd 1999;143:2364-9.
26. Johnson JR, Stamm WE. Urinary tract infections in women: diagnosis and treatment. Ann Intern Med 1989;111:906-17.
27. Zhao C, Li J, Hou J, Guo M, Zhang Y, Chen Y. A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic versus netilmicin in the treatment of bacterial infections. Chin Med J (Engl) 2000;113:1026-30.
28. Ramakrishnan K, Scheid DC. Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician 2005;71:933-42.
29. Perm RG, Preheim LC, Sanders CC, Giger DK, Comparison of moxalactam and gentamicin in the treatment of complicated urinary tract infections. Antimicrob Agents Chemother 1983;24:494-9.
30. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R. Experience with a once-daily aminoglycoside program administered to 2, 184 adult patients. Antimicrob Agents Chemother 1995;39:650-5.
31. Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother 1997;39:677-86.
32. Stamm WE. Scientific and clinical challenges in the management of urinary tract infections. Am J Med 2002-113 (suppl 1A):1S-4S.
33. Hummers-Pradier E, Kochen MM. Urinary tract infections in adult general practice patients. Br J Gen Pract 2002;52:752-61.
34. Andrašević S. Istražlvanje uzročnika infekcija mokraćnog sustava i njihove osjetljivosti na antimikrobna sredstva u ambulantno liječenih i hospitaliziranih bolesnika na Klinici za infektivne bolesti «Dr. Fran Mihaljević» (Magistarski rad). Zagreb: Medicinski fakultet Sveučlišta u Zagrebu; 2006, str. 72.
35. Moore KN, Day RA, Albers M. Pathogenesis of urinary tract infections: a review. J Clin Nurs 2002-11:568-74.
36. Sobel JD, Kaye D. Urinary tract infection. U: Mandell GL, Bennet JE, Dolin R, ur. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. New York: Elsevier/Churchill Livingstone; 2005: 875-905.
37. Colgan R, Nicoiie LE, McGlone A, Hooton TM. Asymptomatic bacteriuria in adults. Am Fam Phys 2006;74:985-90.
38. Hurlbut TA, Littenberg B. The diagnostic accuracy of rapid dipstick test to predict urinary tract infection. Am J Clin Pathol 1991;96:582-8.
39. Thysell H. Evaluation of chemical and microscopical methods for mass detection of bacteriuria. Acta Med Scand 1969;185:393-400.
40. European Confederation of Laboratory Medicine. European urinalysis guidelines. Scand J Clin Lab Invest 2000;231:1-86.
41. Komaroff AL, Pass TM, McCue JD, Cohen AB, Hendricks TM, Friedland G. Management strategies for urinary and vaginal infections. Arch Intern Med 1978;138:1069-73.
42. Perm RG, Griffin JP. Adverse reactions to nitrofurantoin in the United Kingdom, Sweden and Holland. Br Med J 1982;284:1440-2.
43. Dam-Larsen S, Kromann-Andersen H. Hepatic toxicity of nitrofurantoin. Cases reported to the Center for Monitoring Adverse Drug Reactions 1968-1998. Ugeskr Laeger 1999;161:6650-2.
44. Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007;167:2207-12.
45. Ernst EJ, Ernst ME, Hoehns JD, Bergus GR. Women's quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. Health Qual Life Outcomes 2005;3:45.
46. Goettsch WG, Janknegt R, Herings RM. Increased treatment failure after 3-daysž courses of nitrofurantoin and trimetoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database. Br J Clin Pharmacol 2004;58:184-9.
47. Karlowicz KA. Pharmacologic therapy for acute cystitis in adults: a review of treatment options. Urol Nurs 1997;17:106-14.
48. Hooton TM, Scholes D, Gupta K, Stapleton AE, Roberts PL, Stamm WE. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 2005;293: 949-55.
49. Nicolle LE. Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother 2000;46 (Suppl 1):35-9.
50. Vicković N. Optimalizacija liječenja akutnog cistitisa antimikrobnim lijekovima (Magistarski rad). Zagreb: Medicinski fakultet Sveučilišta u Zagrebu; 2006, str. 65.
51. Katehman EA, Milo G, Paul M, Cristiaens T, Baerheim A, Leibovici L. Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis. Am J Med 2005-118: 1196-207.
52. Nicolle L, Anderson PA, Conly J i sur. Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment. Can Fam Phys 2006;52:612-8.
53. Thomson KS, Sanders WE, Sanders CC. USA resistance patterns among UTI pathogens. J Antimicrob Chemother 1994;33:9-15.
54. Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am 2003;17:243-59.
55. Roberts FJ. Quantitative urine culture in patients with urinary tract infection and bacteremia. Am J Clin Pathol 1986;85:616-8.
56. Finch RG, Greenwood D, Norrby SR, Whitley RJ, ur. Antibiotic and Chemotherapy: Anti-inefective agents and their use in therapy. New York: Churchill Livingstone; 2003, str. 273-5.
57. RXList: The Internet Drug Index. Augmentin. Clinical Pharmacology. Clinical studies. URL: http://www.rxlist.com/cgi/generic/amoxclav-cp.htm
58. Carson C, Naber KG. Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections. Drugs 2004;64:1359-73.
59. Naber KG, Koch EM. Cefuroxime axetil versus ofloxacin for shortterm therapy of acute uncomplicated lower urinary tract infections in women. Infection 1993;21:34-9.
60. Stein GE, Christensen S, Mummaw N. Treatment of acute uncomplicated urinary tract infection with ceftibuten. Infection 1991;19:124-6.
61. Hooton TM. The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am 2003-17:303-32.
62. Duff P. The aminoglycosides. Obstet Gynecol Clin North Am 1992-19:511-7.
63. Wagenlehner FM, Naber KG. Uncomplicated urinary tract infections in women. Curr Opin Urol 2001-11:49-53.
64. Talan DA, Stamm WE, Hooton TM i sur. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 2000-283:1583-90.
65. Elkharrat DM, Veyssier P, Botto H i sur. A 7-day ciprofloxacin (Cip) regimen for community-acquired acute uncomplicated pyelonephritis (AUP) in adults: a prospective multicenter study in the emergency department (ED). Abstr Intersci Conf Antimicrob Agents Chemother 2003;43:L262.
66. Barnes AI, Herrero IL, Albesa I. New aspect of the synergistic antibacterial action of ampicilin and gentamicin. Int J Antimicrob Agents 2005;26:146-51.
67. Grzybowska W, Wojcik A, Tyski S. Interaction of neomycin with other antibiotics on selected bacterial strains. Med Dosw Mikrobiol 2004-56:187-98.
68. Ulleryd P. Febrile urinary tract infection in men. Int J Antimicrob Agents 2003;22 (Suppl 2):89-93.
69. Naber KG, Sorgel F. Antibiotic therapy - rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue. Andrologia 2003:35:331-5.
70. Wagenlehner FM, Naber KG. Current challenges in the treatment of complicated urinary tract infections and prostatitis. Clin Microbiol Infect 2006;12 (Suppl 3):67-80.
71. Leigh DA. Prostatitis - an increasing clinical problem for diagnosis and management. J Antimicrob Chemother 1993;32 (Suppl A):1-9.
72. Stevermer JJ, Easley SK. Treatment of prostatitis. Am Fam Phys 2000-61:3015-22.
73. Ulleiyd P, Sandberg T. Ciprofloxacin for two or four weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a one year follow-up. Scand J Infect Dis 2003;35:34-9.
74. Naber KG, Busch W, Focht J. Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. The German Prostatitis Study Group. Int J Antimicrob Agents 2000-14:143-9.
75. Nicolle LE, Bradley S, Colgan R i sur. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643-54.
76. Warren JW, Damron D, Tenney JH, Hoopes JM, Deforge B, Muncie HL. Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters. J Infect Dis 1987-155:1151-8.
77. Steward DK, Wood GL, Cohen RL, Smith JW, Mackowiak PA. Failure of the urinalysis and quantitative urine culture in diagnosing symptomatic urinary tract infections in patients with long-term urinary catheters. Am J Infect Control 1985;13:154-60.
78. Vtckrey BG, Shekelle P, Morton S, Clark K, Pathak M, Kamberg C. Prevention and management of urinary tract infections in paralyzed persons. Evid Rep Technol Assess 1999;6:1-3.
79. Tambyah PA, Maki DG. The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients. Arch Intern Med 2000;160:673-7.
80. Nicolle LE, Mayhew WJ, Bryan L. Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med 1987;83:27-33.
81. Warren JW, Anthony WC, Hoopes JM, Muncie HL. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA 1982;248:454-8.
82. Nicolle LE. Urinary tract infections in long-term-care facilities. Infect Control Hosp Epidemiol 2001;22:167-75.
83. Taiwo SS, Aderounmu AOA. Catheter associated urinary tract infection: aetiologic agents and antimicrobial susceptibility pattern in Ladoke Akintola University Teaching Hospital, Osogbo, Nigeria. Afr J Biomed Res 2006;9:141-8.
84. Gammack J. Use and management of chronic urinary catheters in longterm care: much controversy, little consensus. J Am Med Dir Assoc 2003;4 (2 suppl):S52-9.
85. Berman P, Hogan DB, Fox RA. The atypical presentation of infection in old age. Age Ageing 1987;16:201-7.
86. Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med 2000;160:678-82.
87. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight. Obstet Gyn 1989;73:576-82.
88. Quiroga-Feuchter G, Robles-Torres RE, Ruelas-Moran A, Gómez-Alcalá AV. Asymptomatic bacteriuria among pregnant women. An underestimated threat. Rev Med Inst Mex Seguro Soc 2007;45:169-72.
89. Krcmery S, Hromec J, Demesova D. Treatment of lower urinary tract infection in pregnancy. Int J Antimicrob Agents 2001-17:279-82.
90. Millar LK, Wing DA, Paul RH, Grimes DA. Outpatient treatment of pyelonephritis in pregnancy: a randomized controlled trial. Obstet Gynecol 1995;86:560-4.
91. Kämmerer W, Mutschler E. Drugs in pregnancy - an overview. U: Freise K, Melchert F, ur. Arzneimitteltherapie in der Frauenheilkunde. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2002.
92. Boothby LA, Doering PL. FDA labeling system for drugs in pregnancy. Ann Pharmacother 2001;35:1485-9.
93. Raz R. Asymptomatic bacteriuria. Clinical significance and management. Int J Antimicrob Agents 2003;22 (suppl 2):45-7.
94. Smaill F, Vazquez J. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2007;(2):CD000490
95. Rutala WA, Kennedy VA, Loflin HB, Sarubbi FA. Serratia marcescens nosocomial infections of the urinary tract associated with urine measuring containers and urinometers. Am J Med 1981;70:659-63.
96. Maki DG, Hennekens CG, Phillips CW, Shaw WV, Bennett JV. Nosocomial urinary tract infection with Serratia marcescens: an epidemiologic study. J Infect Dis 1973;128:579-87.
97. Schaberg DR, Weinstein RA, Stamm WE. Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis 1976;133:363-6.
98. Harding GK, Nicolle LE, Ronald AR i sur. How long should catheteracquired urinary tract infection in women be treated? A randomized controlled study. Ann Intern Med 1991;114:713-9.
99. David TS, Vrahas MS. Perioperative lower urinary tract infections and deep sepsis in patients undergoing total joint arthroplasty. J Am Acad Orthop Surg 2000;8:66-74.
100. MacKenzie RC. Perioperative Medical Care of Rheumatic Disease Patients Having Orthopaedic Surgery. URL: http://hss.edu/conditions-13578.asp
101. Levi N. Urinary tract infection and cervical hip fracture. Int J Risk Safety Med 1998;11:41-4.
102. Hooten TM. Epidemiology. U: Stanton SL, Dwyer PL, ur. Urinary tract infection in the female. London: Dunitz M; 2000, str. 1-18.
103. Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents 2001;17:259-68.
104. Harding GK, Ronald AR, Nicolle LE, Thomson MJ, Gray GJ. Longterm antimicrobial prophylaxis for recurrent urinary tract infection in women. Rev Infect Dis 1982;4:438-43.
105. Nicolle LE, Harding GK, Thomson M, Kennedy J, Urias B, Ronald AR. Efficacy of five years of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection. J Infect Dis 1988;157:1239-42.
106. Schönwald S, Škerk V, Puntarić i sur. Djelotvornost i podnošljivost profilaktičke primjene nitrofurantoina u žena s rekurentnim nekompliciranim infekcijama donjeg mokračnog sustava. Infektol Glasn 2002;22:97-100.
107. Vosti KL. Recurrent urinary tract infections. Prevention by prophylactic antibiotics after sexual intercourse. JAMA 1975;231:934-40.
108. Stapleton A, Stamm WE. Prevention of urinary tract infection. Infect Dis Clin North Am 1997;11:719-33.
109. Jepson RG, Craig JC. A systematic review of the evidence for cranberries and blueberries in UTI prevention. Mol Nutr Food Res 2007-51:738-45.
110. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002;9:1558-62.
111. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. Brit Med J 2001:322:1571.
112. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753-6.
113. Crandall C. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy. J Womens Health (Larchmt) 2002-11:857-77.
114. Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JW Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev 1990;3:335-44.
115. Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001;73 (2 Suppl):437S-443S.
116. Škerk V, Tambić-Andrašević A, Ferinčević R i sur. Ispitivanje djelotvornosti i podnošljivosti vaginalne primjene probiotika Lactobacillus acidophilus u žena sa simptomima kolpitisa. Infektol Glasn 2007-27:81-5.
117. Kass EH. Bacteriuria and the diagnosis of infections of the urinary tract with observations on the use of methionine as a urinary antiseptic. Arch Intern Med 1957;100:709-14.
118. Kučišec-Tepeš N, Bejuk D, ur. EU: Europske upute za analizu urina. Zagreb: Hrvatski lijeičnički zbor; 2000.